1 – 10 of 222
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2025
- False-positive MOG antibodies in a patient with a slow-progressive intramedullary glioma (2025) NEUROLOGY. 105(6).
- 2024
- Disease control and late toxicity in adaptive dose painting by numbers versus nonadaptive radiation therapy for head and neck cancer : a randomized controlled phase 2 trial (2024) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 120(2). p.516-527
- 2022
- JoVE video dataset (2022)
- Positron emission tomography-based dose painting radiation therapy in a glioblastoma rat model using the small animal radiation research platform (2022) JOVE-JOURNAL OF VISUALIZED EXPERIMENTS. 181.
- Retrospective real-life study on preoperative imaging for minimally invasive parathyroidectomy in primary hyperparathyroidism (2022) SCIENTIFIC REPORTS. 12(1).
- Perspective on the use of DNA repair inhibitors as a tool for imaging and radionuclide therapy of glioblastoma (2022) CANCERS. 14(7).
- 2021
- Is there a role for 18F-FDG PET-CT in Familial Mediterranean fever? A case report and overview of the literature (2021) RADIOLOGY CASE REPORTS. 16(7). p.1700-1707
- Comparison of an in-house acquired brain F-18 FDG PET normal database with commercially available normal data (2021) NUCLEAR MEDICINE COMMUNICATIONS. 42(9). p.1039-1044
- Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI (2021) PLOS ONE. 16(3).
- A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma (2021) THERANOSTICS. 11(16). p.7911-7947